Mesa Labs in $180m Gyros acquisition for biopharma asset development
Mesa Labs buys Gyros to gain access to the latter’s capabilities in the discovery, development and manufacture of biotherapeutics.
Archives for November 12, 2019
Marc Funk to exit as CEO of Lonza after one year
Lonza announces that its CEO will leave his position after one year in the role due to personal reasons.